INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,005,000 | -29.0% | 85,312 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $2,823,000 | +2.0% | 103,642 | +3.1% | 0.00% | -50.0% |
| Q3 2021 | $2,769,000 | +7.2% | 100,535 | +10.7% | 0.00% | +100.0% |
| Q2 2021 | $2,584,000 | -19.0% | 90,797 | -3.1% | 0.00% | -50.0% |
| Q1 2021 | $3,192,000 | +10.3% | 93,725 | +7.8% | 0.00% | 0.0% |
| Q4 2020 | $2,895,000 | +11.8% | 86,976 | +8.0% | 0.00% | 0.0% |
| Q3 2020 | $2,589,000 | +16.2% | 80,557 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $2,228,000 | +63.8% | 80,904 | -4.6% | 0.00% | +100.0% |
| Q1 2020 | $1,360,000 | -57.9% | 84,817 | -37.3% | 0.00% | -50.0% |
| Q4 2019 | $3,232,000 | +27.1% | 135,324 | -6.1% | 0.00% | 0.0% |
| Q3 2019 | $2,542,000 | +6.6% | 144,100 | +54.8% | 0.00% | 0.0% |
| Q2 2019 | $2,384,000 | +33.3% | 93,116 | +51.4% | 0.00% | 0.0% |
| Q1 2019 | $1,788,000 | +96.1% | 61,518 | -11.5% | 0.00% | +100.0% |
| Q4 2018 | $912,000 | -29.6% | 69,534 | +8.6% | 0.00% | 0.0% |
| Q3 2018 | $1,295,000 | -39.1% | 64,032 | -28.8% | 0.00% | -50.0% |
| Q2 2018 | $2,128,000 | +219.5% | 89,987 | +204.2% | 0.00% | +100.0% |
| Q1 2018 | $666,000 | -64.7% | 29,584 | -51.2% | 0.00% | -50.0% |
| Q4 2017 | $1,889,000 | +11.2% | 60,585 | +11.3% | 0.00% | 0.0% |
| Q3 2017 | $1,698,000 | +517.5% | 54,415 | +239.4% | 0.00% | – |
| Q2 2017 | $275,000 | +9.1% | 16,035 | +11.2% | 0.00% | – |
| Q1 2017 | $252,000 | +83.9% | 14,417 | +39.2% | 0.00% | – |
| Q4 2016 | $137,000 | -46.5% | 10,354 | -1.3% | 0.00% | -100.0% |
| Q2 2015 | $256,000 | -37.6% | 10,492 | -60.5% | 0.00% | 0.0% |
| Q4 2014 | $410,000 | +11.1% | 26,535 | -6.2% | 0.00% | 0.0% |
| Q3 2014 | $369,000 | -47.4% | 28,301 | -19.4% | 0.00% | -50.0% |
| Q2 2014 | $702,000 | +8.3% | 35,123 | +3.1% | 0.00% | 0.0% |
| Q1 2014 | $648,000 | +42.7% | 34,055 | +27.4% | 0.00% | +100.0% |
| Q4 2013 | $454,000 | +51.8% | 26,728 | +39.4% | 0.00% | 0.0% |
| Q3 2013 | $299,000 | – | 19,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |